期刊文献+

黄体酮热熔压敏胶透皮贴剂的制备及其体外释药性能研究 被引量:5

Preparation and in vitro release characterization of hot-melt pressure sensitive adhesive transdermal patch of progesterone
下载PDF
导出
摘要 目的制备黄体酮热熔压敏胶透皮贴剂并考察其体外释药性能。方法采用苯乙烯-异戊二烯-苯乙烯热塑性弹性体热熔压敏胶为骨架材料,以大鼠离体皮肤为渗透屏障,采用改良Freeze扩散池,用HPLC法测定接收液浓度,筛选促渗剂的种类、浓度和涂布厚度,确定贴剂处方。结果促渗剂选择肉豆蔻酸异丙酯(IPM),含量为2%;选择涂布厚度为300μm,得到累积渗透曲线为Q=6.172 1 t-5.457 7(r=0.998 8);24h药物累积渗透量为144.17μg/cm^2;稳态渗透速率为(6.17±0.49)μg/(cm^2·h)。结论制备的黄体酮热熔压敏胶透皮贴剂中的有效成分黄体酮体外经皮渗透良好,具有较好的临床应用前景。 Objective To prepare hot-melt pressure sensitive adhesive (HMPSA) transdermal patches of progesterone and investigate the release characterization in vitro. Methods SIS HMPSA was used as matrix material, modified Franz diffu- sion cell and excised female rat skin were used as model, the concentration of progesterone was determined by HPLC. The thickness of patch and penetration enhancers was screened out by permeation rate. Results 2% IPM was used to prepare pro- gesterone HMPSA transdermal patch, thickness was 300 μm, the cumulative permeation curve was Q= 6. 172 1 t=5. 457 7 (r=0.998 8). The cumulative releases of the patches in 24 h was 144. 17 μg/cm2. The permeation rate was (6. 17 ± 0.49) μg/(cm2· h). Conclusion The progesterone HMPSA transdermal patch had good transdermal release in vitro, which would have good clinical application prospect.
出处 《药学实践杂志》 CAS 2016年第1期44-47,共4页 Journal of Pharmaceutical Practice
关键词 黄体酮 热熔压敏胶透皮贴剂 经皮渗透 肉豆蔻酸异丙酯 progesterone HMPSA percutaneous penetration IPM
  • 相关文献

参考文献7

二级参考文献78

  • 1吴宋夏,王宗锐,谌小红,杨金英.薄荷醇促皮渗透作用研究[J].中国医院药学杂志,1994,14(8):366-368. 被引量:43
  • 2周萍,徐菊芬.马铃薯外敷治疗黄体酮肌肉注射臀部硬结的探讨[J].实用临床医药杂志,2005,9(4):54-54. 被引量:16
  • 3李静,刘丽.黄体酮和黄体酮β-环糊精溶解速率的比较[J].天津药学,1996,8(1):14-15. 被引量:3
  • 4郑金生 王咪咪 等.本草纲目[M].北京:人民卫生出版社,1994.1676.
  • 5Simon JA,Robinsomn OE,Andrews MC et al.The absorption of oral micronized progesterone:the effect of food,dose proportionality,and comparison wit intramuscular progesterone[J].Fertil Steril,1993,60:26.
  • 6Maxson WS,Hargrove JT.Bioavailability of oral micronized progesterone[J].Fertil Steril,1985,44:622.
  • 7Nillius SJ,Johansson ED.Plasma levels of progesterone after vaginal,rectal,or intramuscular administration of progesterone[J].Am J Obstetet Gynecol,1971,110:470.
  • 8Stanczyk FZ,Gent zschein E,Ary BA,et al.Urinary progesterone and pregnanediol:Use for monitoring progesterone treatment[J].J Reprod Med,1997,42:216.
  • 9Hermsmyer K.Blood levels of progesterone achiev ed with a percutaneous cream in postmenopausal women (abstr)[J].Proc of the Third International Symposium,Women' Health and Menopause,Florence,Italy,June 1998,13:16.
  • 10Cicinelli E,Lee EJ,Ang SB,et al.Progesterone administration by nasal spray[J].Fertil Steril,1991,56:139.

共引文献88

同被引文献66

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部